| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 1886 | 2018 |
| Estrogen receptor–positive, progesterone receptor–negative breast cancer: association with growth factor receptor expression and tamoxifen resistance G Arpino, H Weiss, AV Lee, R Schiff, S De Placido, CK Osborne, ... Journal of the National Cancer Institute 97 (17), 1254-1261, 2005 | 596 | 2005 |
| Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy X Cui, R Schiff, G Arpino, CK Osborne, AV Lee Journal of clinical oncology 23 (30), 7721-7735, 2005 | 590 | 2005 |
| Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo AV Lee, JG Jackson, JL Gooch, SG Hilsenbeck, E Coronado-Heinsohn, ... Molecular endocrinology 13 (5), 787-796, 1999 | 432 | 1999 |
| Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases S Liu, M Umezu-Goto, M Murph, Y Lu, W Liu, F Zhang, S Yu, LC Stephens, ... Cancer cell 15 (6), 539-550, 2009 | 417 | 2009 |
| MCF-7 cells—changing the course of breast cancer research and care for 45 years AV Lee, S Oesterreich, NE Davidson JNCI: Journal of the National Cancer Institute 107 (7), 2015 | 312 | 2015 |
| Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer CJ Creighton, X Fu, BT Hennessy, AJ Casa, Y Zhang, ... Breast cancer research 12, 1-12, 2010 | 294 | 2010 |
| Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway … X Cui, P Zhang, W Deng, S Oesterreich, Y Lu, GB Mills, AV Lee Molecular endocrinology 17 (4), 575-588, 2003 | 290 | 2003 |
| Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis CJ Creighton, A Casa, ZW Lazard, S Huang, A Tsimelzon, SG Hilsenbeck, ... Journal of clinical oncology 26 (25), 4078, 2008 | 286 | 2008 |
| Crosstalk between the insulin-like growth factors and estrogens in breast cancer D Yee, AV Lee Journal of mammary gland biology and neoplasia 5, 107-115, 2000 | 286 | 2000 |
| Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an … HJ Kim, BC Litzenburger, X Cui, DA Delgado, BC Grabiner, X Lin, ... Molecular and cellular biology 27 (8), 3165-3175, 2007 | 276 | 2007 |
| Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells AV Lee, CN Weng, JG Jackson, D Yee Journal of Endocrinology 152 (1), 39-47, 1997 | 246 | 1997 |
| Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor JM Carboni, AV Lee, DL Hadsell, BR Rowley, FY Lee, DK Bol, ... Cancer research 65 (9), 3781-3787, 2005 | 242 | 2005 |
| Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. RL Rocha, SG Hilsenbeck, JG Jackson, CL VanDenBerg, C Weng, ... Clinical cancer research: an official journal of the American Association …, 1997 | 227 | 1997 |
| AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice SQ Kuang, L Liao, H Zhang, AV Lee, BW O’Malley, J Xu Cancer research 64 (5), 1875-1885, 2004 | 224 | 2004 |
| Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2 RK Dearth, X Cui, HJ Kim, DL Hadsell, AV Lee Cell cycle 6 (6), 705-713, 2007 | 206 | 2007 |
| Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2 RK Dearth, X Cui, HJ Kim, I Kuiatse, NA Lawrence, X Zhang, J Divisova, ... Molecular and cellular biology 26 (24), 9302-9314, 2006 | 202 | 2006 |
| A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells D Sachdev, JS Hartell, AV Lee, X Zhang, D Yee Journal of Biological Chemistry 279 (6), 5017-5024, 2004 | 201 | 2004 |
| Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth S Oesterreich, P Zhang, RL Guler, X Sun, EM Curran, WV Welshons, ... Cancer research 61 (15), 5771-5777, 2001 | 198 | 2001 |
| Sensitive Detection of Mono-and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsESR1 Mutations in Advanced Breast Cancer P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ... Clinical cancer research 22 (5), 1130-1137, 2016 | 197 | 2016 |
Steffi OesterreichUniversity of PittsburghVerified email at upmc.edu
